Phase 3 Development and Current Evidence Level Retatrutide is in phase 3 development for several metabolic indications, including obesity and type 2 diabetes, while published phase 2 trials and 2026 phase 3 reports provide the main current human evidence [2], [7], [8]
Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Your clinician will monitor your progress and how well your body responds to Wegovy as you titrate up the dosage schedule
100% natural Mushroom Complex 6 HIGH STRENGTH is an equal mix of Price range: 23.99 through 56.99
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access 269,00 per year only 22,42 per issue Rent or buy this article Prices vary by article type from$1.95 to$39.95 Prices may be subject to local taxes which are calculated during checkout Subjects References McMurray, J